What are Orally Disintegrating Tablets (ODTs)?

ODTs are pharmaceutical dosage forms that dissolve rapidly in the mouth without the need for water, making them convenient for patients with swallowing difficulties.

How big is the Orally Disintegrating Tablet Market?

The global Orally Disintegrating Tablet Market size was estimated at USD 21.3 Billion in 2023 and is expected to reach USD 49.1 Billion in 2033.

What is the Orally Disintegrating Tablet Market growth?

The global Orally Disintegrating Tablet Market is expected to grow at a compound annual growth rate of 8.7%. From 2024 To 2033

Who are the key companies/players in the Orally Disintegrating Tablet Market?

Some of the key players in the Orally Disintegrating Tablet Markets are AstraZeneca plc., Mylan N.V., Pfizer Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bausch Health, GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Bayer AG, Eli Lily and Company, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Other Key Players.

What trends are shaping the ODT Market?

Trends include the use of natural and organic ingredients, personalized medicine, and a focus on technologically advanced products.

What are the challenges faced by the ODT Market?

Challenges include regulatory complexities, manufacturing costs, and the need for specialized equipment.

Global Orally Disintegrating Tablet Market By Drug Class (Anti-Epileptics, Anti-Psychotics, Anti-Hypertensives, Proton Pump Inhibitors, Other Drug Classes) By Disease Indication (CNS Diseases, CVS Disorders, GI Diseases, Other Disease Indications) By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Drug Stores) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2024
Report ID: 13004
Number of Pages: 304
Format:

- AstraZeneca plc.
- Mylan N.V.
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Bausch Health
- GlaxoSmithKline plc.
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Eli Lily and Company
- Dr. Reddy’s Laboratories Ltd.
- Takeda Pharmaceutical Company Limited
- Other Key Players